Literature DB >> 21383739

Resistance, epigenetics and the cancer ecosystem.

Stephen B Baylin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21383739     DOI： 10.1038/nm0311-288

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  Stress and the epigenetic landscape: a link to the pathobiology of human diseases?

Authors:  Sarah E Johnstone; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2010-10-05       Impact factor: 53.242

3.  Dynamic proteomics of individual cancer cells in response to a drug.

Authors:  A A Cohen; N Geva-Zatorsky; E Eden; M Frenkel-Morgenstern; I Issaeva; A Sigal; R Milo; C Cohen-Saidon; Y Liron; Z Kam; L Cohen; T Danon; N Perzov; U Alon
Journal:  Science       Date:  2008-11-20       Impact factor: 47.728

4.  Dissecting direct reprogramming through integrative genomic analysis.

Authors:  Tarjei S Mikkelsen; Jacob Hanna; Xiaolan Zhang; Manching Ku; Marius Wernig; Patrick Schorderet; Bradley E Bernstein; Rudolf Jaenisch; Eric S Lander; Alexander Meissner
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

5.  Shifting paradigms: the seeds of oncogene addiction.

Authors:  Charles L Sawyers
Journal:  Nat Med       Date:  2009-10       Impact factor: 53.440

6.  Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?

Authors:  Terry J Gaymes; Rose Ann Padua; Marika Pla; Stephen Orr; Nader Omidvar; Christine Chomienne; Ghulam J Mufti; Feyruz V Rassool
Journal:  Mol Cancer Res       Date:  2006-08       Impact factor: 5.852

Review 7.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

8.  The retinoblastoma binding protein RBP2 is an H3K4 demethylase.

Authors:  Robert J Klose; Qin Yan; Zuzana Tothova; Kenichi Yamane; Hediye Erdjument-Bromage; Paul Tempst; D Gary Gilliland; Yi Zhang; William G Kaelin
Journal:  Cell       Date:  2007-02-22       Impact factor: 41.582

Review 9.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

10.  Drug resistance, epigenetics, and tumor cell heterogeneity.

Authors:  Timothy Hoey
Journal:  Sci Transl Med       Date:  2010-04-21       Impact factor: 17.956
View more
  25 in total

Review 1.  [The epigenome. Target for innovative therapies in head and neck carcinoma].

Authors:  A Leipold; J Hess; K Zaoui
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

2.  Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium.

Authors:  Laura Cartularo; Freda Laulicht; Hong Sun; Thomas Kluz; Jonathan H Freedman; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2015-08-24       Impact factor: 4.219

Review 3.  How does genome sequencing impact surgery?

Authors:  Marlies S Reimers; Charla C Engels; Peter J K Kuppen; Cornelis J H van de Velde; Gerrit J Liefers
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

4.  Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles.

Authors:  Jingwei Ma; Yi Zhang; Ke Tang; Huafeng Zhang; Xiaonan Yin; Yong Li; Pingwei Xu; Yanling Sun; Ruihua Ma; Tiantian Ji; Junwei Chen; Shuang Zhang; Tianzhen Zhang; Shunqun Luo; Yang Jin; Xiuli Luo; Chengyin Li; Hongwei Gong; Zhixiong Long; Jinzhi Lu; Zhuowei Hu; Xuetao Cao; Ning Wang; Xiangliang Yang; Bo Huang
Journal:  Cell Res       Date:  2016-05-10       Impact factor: 25.617

Review 5.  Tumor cell plasticity: the challenge to catch a moving target.

Authors:  Sarah Schwitalla
Journal:  J Gastroenterol       Date:  2014-02-25       Impact factor: 7.527

6.  Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.

Authors:  P-H Liao; H-H Hsu; T-S Chen; M-C Chen; C-H Day; C-C Tu; Y-M Lin; F-J Tsai; W-W Kuo; C-Y Huang
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

Review 7.  Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

Authors:  Michael Hölzel; Anton Bovier; Thomas Tüting
Journal:  Nat Rev Cancer       Date:  2013-03-28       Impact factor: 60.716

Review 8.  Novel agents in acute myeloid leukemia.

Authors:  Alexander Ungewickell; Bruno C Medeiros
Journal:  Int J Hematol       Date:  2012-08-06       Impact factor: 2.490

9.  A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene.

Authors:  Hui Wei; Tapan K Bera; Alan S Wayne; Laiman Xiang; Simona Colantonio; Oleg Chertov; Ira Pastan
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

Review 10.  Epigenetics of colorectal cancer.

Authors:  Ajay Goel; C Richard Boland
Journal:  Gastroenterology       Date:  2012-09-20       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.